Form D · Biotechnology

PUMA BIOTECHNOLOGY, INC.

Los Angeles, CA · CIK 0001531754

Offering snapshot reported Oct 12, 2011 · SEC filing

Reported sold
$55M
Offering amount: $55M
Investors reported
27
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 4, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$27.5M$55MOct 4, 2011: $55,000,249.00Oct 4, 2011Oct 4, 2011: $55,000,249.00Oct 12, 2011: $55,000,249.00Oct 12, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported investors14 → 27

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2011Amendment$55,000,249$0vs Oct 4, 201127SEC filing
Oct 4, 2011Initial$55,000,249No comparison14SEC filing
Oct 4, 2011Amendment$55,000,249$0vs Oct 4, 201114SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$2.34M
Finders' fees
$0
Form D file number
021-166750

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Leerink Swann LLC39011

Source: Form D, filed Oct 12, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alan H. Auerbach Director, Executive
Charles R. Eyler Executive
Thomas R. Malley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
10940 Wilshire Blvd. Suite 600
Los Angeles, CA, 90024